论文部分内容阅读
目的 探索肝动脉栓塞新材料的临床应用。方法 5 2例病人分别用中药白芨 (用 40 %碘化油作载体 )和明胶海绵 2种不同栓塞剂 ,进行中央性栓塞 ,观察这 2种栓塞剂的临床疗效。结果 中药白芨栓塞剂组 ,血管再通率和侧枝循环形成低于明胶海绵组。肝区疼痛、发热、肝功能损害等副作用较明胶海绵组重。结论 白芨做肝动脉栓塞剂 ,能有效防止中晚期肝癌灌注化疗、栓塞后血管再通和侧枝循环形成 ,但副作用较明胶海绵为重。
Objective To explore the clinical application of new materials for hepatic artery embolization. Methods 52 cases of patients were treated with traditional Chinese medicine Baiji (using 40% iodized oil as carrier) and gelatin sponge as two different embolic agents to perform central embolization. The clinical efficacy of the two embolic agents was observed. Results Compared with the gelatin sponge group, the rate of recanalization and collateral circulation was lower in the traditional Chinese medicine group. Liver area pain, fever, liver damage and other side effects than gelatin sponge group weight. Conclusion The use of alum in the treatment of hepatic arterial embolization can effectively prevent middle-late stage hepatocellular carcinoma infusion chemotherapy, vascular recanalization and collateral circulation formation after embolization, but the side effects are more important than gelatin sponge.